LGALS3 and breast carcinoma: Relatedly, cleaved galectin-3 has been reported as a novel surrogate marker for MMP activity in growing breast cancers.67 We, therefore, postulate that MMP12 can target and cleave galectin-3 promoting an antifibrotic response and perpetuating inflammation.